• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

asset sale

sold
Favicon Fierce Biotech

Charles River sells CDMO and discovery assets in strategic pivot

The CRO is offloading its contract manufacturing operation and some of its European discovery services, which brought in $287 million last year.
Darren Incorvaia Feb 25, 2026 1:54pm
Cambrex North Carolina

Permira eyes $4B sale of CDMO Cambrex: FT

Sep 9, 2025 10:36am
Pfizer

Pfizer explores sale of hospital drugs unit: Reuters

Nov 12, 2024 11:09am
pay deal hand over cash licensing transaction money

TerSera picks up MacroGenics' Margenza for $40M plus milestones

Oct 22, 2024 11:33am
pay deal hand over cash licensing transaction money

Sanofi sells rare disease med Enjaymo to Recordati for $825M

Oct 4, 2024 10:11am
Merz Therapeutics Merz CEO Stefan Knig

Merz to expand and hunt for more deals after closing Inbrija buy

Jul 11, 2024 4:08pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings